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Abstract
This work concerns the identification of the alleles of the polymorphic DQB1 gene of the human leuko-
cyte antigen system, conferring susceptibility to the development of insulin-dependent diabetes mellitus
(IDDM) in non-PCR amplified DNA samples and, more importantly, in crude cell extracts. Our method is
based on the time-resolved analysis of a Fo¨rster energy-transfer mechanism that occurs in a dual-labelled
fluorescent probe specific for the IDDM-associated DQB1-0201 allele. Such an oligonucleotide probe is
labelled, at the two ends, by a pair of chromophores that operate as donor and acceptor in a Fo¨rster res-
onant energy transfer. The donor fluorescence is quenched with an efficiency that is strongly dependent
on the donor-to-acceptor distance, hence on the configuration of the probe after hybridization with the
various DQB1 alleles. By time-correlated single-photon counting, performed with an excitation/detection
system endowed with 30-ps resolution, we measure the time-resolved fluorescence decay of the donor and
discriminate, by means of the decay–time value, the DNA bearing the ‘susceptible’ allele from the DNAs
bearing any other sequence in the same region of the DQB1 gene. We could also distinguish the presence
of the DQB1-0201 allele in a homozygous versus a heterozygous condition.
Key words: picosecond-resolved FRET; HLA-DQB1 typing; insulin-dependent diabetes mellitus; time-correlated
single-photon counting
1. Introduction
The human leukocyte antigen (HLA) system
encodes highly polymorphic molecules which are fun-
damental for the triggering of the immune response.
Moreover, it is known that the expression of certain
HLA molecules is associated with the susceptibility
to many autoimmune diseases, including insulin-de-
pendent diabetes mellitus (IDDM).1,2
Distinguishing the subjects with susceptibility
genes, before the onset of the disease, calls for the de-
velopment of rapid high-throughput HLA typing tech-
nologies. On the one hand, such an ambitious aim
seems to contrast with the increasing number of sus-
ceptibility conferring alleles that are being discovered† These authors contributed equally to this work.
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in patients affected by specific pathologies.3 On the
other hand, it is encouraging that a massively parallel
sequencing technology has recently allowed mutation
detection in picolitres of cancer specimens.4 For large-
scale HLA analysis, we decided to set a method allow-
ing the typing of non-PCR amplified genomic DNA,
purified from leukocytes, and non-purified DNA
present in cell lysates.
We adopted a DNA probe, which is depicted in
Fig. 1, matching the sequence of one of the most
common alleles conferring susceptibility to IDDM in
the Caucasian population and, by making a novel
use of Fo¨rster resonant energy transfer (FRET), we
found a method for detecting sequence variations of
even a single nucleotide in DNA template used as
target (see Fig. 2). Markers of susceptibility to IDDM
have been recognized in the HLA-II region and, in par-
ticular, in HLA-II DQA1 and DQB1 loci, coding for the
a and b chains of DQ heterodimer, respectively.5
Extensive molecular studies of HLA-DQ genotype in
patients with IDDM led to correlate the susceptibility
with the polymorphism of a single amino acid in both
DQa and DQb chains.6,7 In particular, the combined
presence of an arginine residue in position 52 of the
DQa chain and of a neutral residue (serine, alanine
or valine) in position 57 of the DQb chain is strongly
associated with diabetes onset. On the contrary, the
presence of aspartic acid at position 57 of DQb
confers resistance to IDDM.2
In the present work we focussed on the typing of
the DQB1 locus by hybridizing target DNAs to a
single probe corresponding to DQB1-0201 ‘suscep-
tible’ allele, which was dual labelled by a fluorescent
reporter in 50 and a non-fluorescing quencher in 30.
In such a probe, the fluorescence of the donor tetra-
methylrhodamine (TAMRA) is quenched via FRET by
the black-hole quencher (BHQ2) depending on the
conformational differences among the hybrids due
to the probe/target mismatches. It is worth noting
that fluorescence quenching by FRET is basic to
many genotyping methods that include a step in
which allele-specific hybridization products must be
recognized. These methods rely on the fact that
FRET removes the excitation energy deposited on the
donor (D) towards the acceptor (A) with an efficiency
that depends on the D-to-A distance. As a result,
when D and A are in close proximity, the D fluores-
cence is weaker than that emitted when they are at
greater distances from each other. Multiple allele-spe-
cific probes, each labelled with a different D–A pair,
can be used for querying allelic sequences.8 The se-
quence of each probe is complementary to a specific
polymorphic sequence and probes are mixed all at
once with the PCR-amplified template. The highly
stringent hybridization conditions allow annealing
only of the perfectly matching probe, which results
in a greater D-to-A distance, thus in an enhanced
fluorescence emission of D. Conversely, as the non-
matching probes preserve the native coiled conform-
ation, their fluorescence is quenched. The genotype
of the template DNA is inferred by assessing which
D is the fluorescing one. We exploit the fact that
FRET can produce quantitatively different fluores-
cence responses depending on the probe–target
hybrid conformation, thus making it feasible SNP
genotyping by means of a single probe. Pioneering
attempts in this direction have been made by
Gaylord et al.9 and, later, by Al Attar et al.10. The
latter group used a cationic polymer conjugated to
the targets as D and monitored the fluorescence in-
tensity of A attached to a single peptide nucleic acid
probe. As the neutral peptide backbone of the probe
did not bind to D, the acceptor A received the excita-
tion energy only upon hybridization of the probe to
the targets. By applying this scheme to typing of ABL
polymorphism in the BCR-ABL oncogene, Al Attar
et al. have determined significantly different values
of the FRET efficiency between D and A when the
probe was hybridized to each of the possible target
Figure 1. FRET probe matching the DQB1-0201 sequence between
codons 51 and 58 (22 bases) and carrying the TAMRA donor
and the BHQ2 quencher, whose structures are shown in the
bottom.
Figure 2. Sequences (antisense) of the region comprising codons
51–60 of the eight relevant DQB1 allelic variants (listed on
the left). Nucleotide changes with respect to DQB1-0201 are
marked. The regions shaded in grey are those not covered by
the oligonucleotide used as a probe (see Fig. 1).
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sequences (i.e. to each of the possible mutated
alleles). Thus, they demonstrated the feasibility of
ABL typing by using a single probe. It is easy to
realize that distinguishing among the hybrids that
our probe forms with the different allelic sequences
by absolute measurements of D-fluorescence inten-
sity is a hopeless approach to the development of a
typing method suitable for non-purified/non-ampli-
fied genomic DNA. Indeed, a high-throughput screen-
ing method based on FRET should work with cellular
lysates, where the DNA concentration is variable
from sample to sample, and utilize detectors whose
response is stable against environmental stray light
conditions. In our approach we quantify the FRET effi-
ciencies of each probe/template hybrid by analysing
the D fluorescence temporal decay on a very fast
time scale. We measure the TAMRA-fluorescence
decay time (tD) upon picosecond laser excitation, at
a wavelength that is only absorbed by this chromo-
phore, and detect the fluorescence by a time-corre-
lated single-photon counting (TCSPC) apparatus,
which is endowed with a temporal resolution of
,30 ps. Though the acquisition rate is less than one
photon per excitation pulse, which ensures the applic-
ability of our technique to the detection of even few
probe–target duplexes, good determinations of the
tD values are done in few minutes due to the mega-
hertz repetition rate of the excitation laser. The slight
differences in the distance of the BHQ2 acceptor
from the TAMRA donor and the consequent differences
in FRET efficiencies produce distinct tD values for the
probe hybridized to each of the allelic sequences.
2. Materials and methods
2.1. Hybridization of oligonucleotides
The D–A pair in the single-stranded dual-labelled
oligonucleotide probe in Fig. 1, D-50(ACGCTGCT
GGGGCTGCCTGCCG)30-A, was the TAMRA analogue
50-Dimethoxytrityloxy-5-[N-((tetramethylrhodaminyl)-
aminohexyl)-3-acrylimido]-20-deoxyUridine-30-[(2-
cyanoethyl)-(N,N-diisopropyl)]-phosphoramidite
(TAMRA) and the black hole quencher 40-(4-Nitro-
phenyldiazo)-20-methoxy-50-methoxy-azobenzene-400-
(N-ethyl)-N-ethyl-2-cyanoethyl-(N,N-diisopropyl)-
phosphoramidite (BHQ2). The dual-labelled probe,
purified by high performance liquid chromatog-
raphy, was purchased from Eurofins MWG Operon
(Ebersberg, Germany). The other oligonucleotides
(see Fig. 2) were purchased from TIB Molbiol
(Genova, Italy). Twenty nanomoles of each lyophi-
lized samples were resuspended with Tris–HCl/
EDTA buffer (pH 7.6; 10 mM ionic strength). The
probe and the target oligonucleotides were
diluted to the same final concentration (500 nM)
and mixed in equal volumes. The mixtures were
gradually heated at a rate of þ38C/min to 988C
and kept at this temperature for 10 min to allow
for the denaturation of secondary structures of
the single strands and to destroy the dimers that
could be present. Each probe–target solution was
then cooled down, at a rate of 218C/min, to a tem-
perature that was lower by 18C than the melting
temperature of the duplex: 738C for the DQB1-
0201 oligonucleotide, 678C for 0302, 648C for
0301, 618C for 05031 and 0402, 588C for 0501,
0502 and 0602. The samples were kept at these
plateau temperatures for 20 min, in order to maxi-
mize annealing. Finally, the hybridized solutions
were slowly brought to room temperature (228C/
min) to be analysed with the TCSPC apparatus.
The whole procedure of temperature-controlled
annealing was carried out in the thermostat of a
ThermoQuest-Finnigan gas chromatograph (San
Jose, CA, USA).
2.2. Hybridization of genomic DNA
Genomic DNA was extracted by standard proce-
dures from five HLA homozygous lymphoblastoid
cell lines, namely PITOUT(DQB1-0201), HOM-2
(DQB1-0501), JVM (DQB1-0301), SAVC (DQB1-
0302), and OLL (DQB1-0402)6 and from the hetero-
zygous cell line RAJI (DQB1 0201-0501; G. Tosi,
personal communication). The quality of DNA was
verified by running the samples on agarose gel.
Although DNA were purified about 20 yrs ago and
stored at 48C, they were not grossly degraded (data
not shown). The DNA concentrations were in the
range of 100–600 mg/ml, depending on the cell
line. The probe was added at 1 pM final concentra-
tion. The procedure of temperature-controlled
annealing performed after DNA denaturation at
988C was similar to that adopted for oligonucleotides,
except for the fact that the samples were put together
in the thermostat and exposed to a sequence of five
20-min periods, in which the plateau temperatures
were set, in order, at the values of 73, 67, 64, 61,
and 588C. These multiple exposures to decreasing
temperature values should allow optimal annealing
of the probe to the DQB1 antisense alleles in the fol-
lowing order: 0201 first, then 0302, 0301, 0402,
and 0501 at last. In the same way we treated 50:50
mixtures of SAVC DNA (0302) with either PITOUT
(0201) or OLL (0402) at equal concentrations
(100 mg/ml) and added, as above, with the probe.
Cell lysates were prepared from PITOUT and RAJI
cells. Briefly, 106 cells were resuspended with 125 ml
of solution A (10 mM Tris–HCl pH 8.3, 100 mM
KCl) plus 110 ml of solution B (10 mM TRIS–HCl pH
8.3, 1% Tween 20, 1% Nonidet P40) added with
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15 ml Proteinase K (10 mg/ml). The cellular suspen-
sions were incubated at 568C for 1 h and at 958C
for 15 min. An aliquot of the cell lysate was incubated
with RNAse A (1 mg/ml) for 2 min at room tempera-
ture and then at 958C for 10 min. Both untreated and
RNAse-treated cell lysates were added with equal
volumes of probe (1 pM final concentration).
Denaturation and annealing were performed as
described for purified DNA samples.
2.3. Measurements of D-fluorescence decay time
All TCSPC measurements were performed at room
temperature. In the case of oligonucleotides the fluor-
escence was detected at 908 with respect to laser ex-
citation and the sample was contained in 1  1 cm
quartz cuvette with four polished windows. Owing to
the smallness of the available sample volumes, in
the cases of both DNAs and lysates we adopted an
epi-fluorescence 20 microscope geometry, in
which 50 ml of the samples contained in 200 ml
microwells were excited and the fluorescence col-
lected along the same direction. The D-fluorescence
was separated from the reflected/back-scattered exci-
tation by a dichroic mirror at 458 (DMLP567,
Thorlabs GmbH, Dachau, Germany). The excitation/
detection apparatus, extensively described in a previ-
ous work of ours,11 is entirely made up of commercial
components. Its main features are excitation pulses at
532 nm (6.4 ps duration at 113 MHz repetition rate),
typically attenuated by a factor of .103 to achieve
single-photon regime in the fluorescence detection;
single-photon avalanche diode with built-in active
quenching circuitry and thermoelectric cooling as
the detector; fluorescence decay patterns recorded
with 2.44 ps/channel resolution; full-width at a half-
maximum duration of the detected excitation pulse
of ,30 ps; time-to-amplitude conversion operated
in reversed start–stop modality so that each detected
photon produced a valid start signal; fluorescence
detected .550 nm; each decay pattern acquired up
to a fixed number of counts at the peak, namely
65535; each acquisition time recorded; each meas-
urement repeated three times at least. The zero of
the time scale was set at the peak channel for all
decay patterns.
In addition to the measurements on the hybrids, we
also measured the fluorescence decay of a solution of
the pure single-stranded probe at the same concen-
tration as in the hybridized samples. Preliminarily to
data analysis, the raw decay patterns acquired for
both this solution and those containing the hybri-
dized oligonucleotides were normalized to the acqui-
sition time and to the absorbance values at 556 nm
(TAMRA peak). The experimental decay data were
treated as described below.
2.3.1. Data analysis for tD determination:
oligonucleotides All decay patterns exhibit
fast initial transients of negligible amplitudes, thus
showing that dual-labelled fluorescent probes left
free in solution are virtually absent in our oligonucleo-
tide samples. Such a fast transient represents the ma-
jority of the fluorescence decay of the solution of the
pure single-stranded probe, in which it is summed to
the slow decay component emitted by free TAMRA.
Thus, after normalizing to acquisition time and
TAMRA absorbance, we subtract this slow component
(with the amplitude and lifetime detected for the
pure single-stranded probe, see below) from all
decays and fit the difference starting from 400 to
800 ps after the peak. For all hybridized oligonucleo-
tide samples we find very good fittings by using single
exponentials whose time constants we interpret as
the tD values (see column (a) in Table 1). As an
example we show the case of the oligonucleotide
mimicking the DQB1-0201 in Fig. 3.
2.3.2. Data analysis for tD determination:
DNAs We apply a modified version of
the procedure described in a previous work of
ours.11 In the case of extracted DNAs, as in all mea-
sured decay patterns, preliminarily normalized to ac-
quisition time and TAMRA absorbance, we recognize
a slow decay component typical of not-quenched
TAMRA, either free in solution or bound to hybridized
probes lacking the BHQ2 acceptor. We subtract this
component from the rough experimental decays of
all the hybridized DNA samples with the initial ampli-
tude and lifetime that we detected in the decay
pattern measured on the solution of pure probe.
Table 1. Values of the TAMRA-donor fluorescence decay time
DQB1-allelic variant (a) Oligonucleotides,
tD+ SD (ps)
(b) DNAs,
tD+ SD (ps)
0201 2725+3 2723+3
0501 2514+3 2512+5
0502 2404+11 NA
05031 2427+2 NA
0602 2430+9 NA
0301 2481+3 2479+3
0302 2599+3 2603+5
0402 2462+3 2466+5
NA, sample not available. tD + standard deviation (three in-
dependent measurements at least on each sample), for the
22-base long dual-labelled DQB1-0201 probe (see Fig. 1)
bound to (a) synthetic oligonucleotides corresponding to
the region between codons 51 and 58 of the listed allelic
variants (see Fig. 2) and (b) purified DNAs extracted from
HLA-homozygous lymphoblastoid cell lines.
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The resulting patterns are normalized to their inte-
grals. In the case of cell lysates we detect a further
slow-decay component (5 ns) that is typical of
flavine mononucleotide, which is the main endogen-
ous fluorofore absorbing light at 532 nm. We subtract
this component from the experimental decays mea-
sured for the lysates before proceeding as above. In
both cases, the resulting patterns are normalized to
their integrals.
Let us call the resulting normalized decay patterns
Fx,i, where ‘x’ denotes the genotype and ‘i’ stands for
either extracted-DNA samples (i ¼ EX) or lysate (i ¼
LY) samples. The subtraction of not-quenched
TAMRA contribution is performed also on the probe
decay pattern, which is then normalized to its integral
to obtain FPROBE. We then observe that FPROBE is well
fitted by a three-exponential decays
YPROBEðtÞ ¼ A1Pexp t
t1P
 
þ A2Pexp t
t2P
 
þ A3Pexp t
t3P
 
ð1Þ
The best procedure we found to get rid of the FPROBE
contributions in the decays Fx,i is as follows: we carry
out multi-exponential fits of the latter decays from
which we only extract the values A1x,i, A2x,i, and A3x,i
of the three fastest components and use them to
perform the following weighted subtractions
Fx;i 
A1x;i þ A2x;i þ A3x;i
A1P þ A2P þ A3P FPROBE ; Dx;i ð2Þ
that yield the final curves Dx,i Curves Dx,i should only
contain the fluorescence arising from the desired
double-stranded fraction of each sample with decay
time tD and, possibly, from the probe molecules par-
tially annealed to other regions of the genomic DNA
target. Actually, all curves Dx,i had dynamic ranges
covering more than one decade. In the case of
homozygous genotypes the Dx,i curves exhibited bi-
exponential decays starting from 500 ps after the
peak. Best fits of the Dx,i curves provide the values of
the corresponding decay times t0 and tD. The whole
procedure is illustrated in Fig. 4 for the DNA extracted
from the PITOUT cell line, homozygous for the DQB1-
0201 allelic variant.
3. Results
3.1. Identification of the hybrids formed by allele-
specific HLA-II DQB1 oligonucleotides and the
0201 oligoprobe
In order to establish our FRET-based HLA-II DQB1
typing method we first set the system by using the
panel of synthetic oligonucleotides listed in Fig. 2.
These oligonucleotides are complementary to the
coding sequences of the eight relevant DQB1 alleles
and encompass codons of 51–60.6 Nucleotide varia-
tions with respect to the 0201 allele, shown on the
top, are underlined. Each oligonucleotide was hybri-
dized with the probe corresponding to the 0201
variant having the GCC codon for alanine in position
57. The oligoprobe and the structures of the TAMRA
donor and BHQ2 acceptor molecules are shown in
Fig. 1. In general, to increase the specificity of a
probe for its target DNA, it is desirable to design the
oligonucleotide with a great rather than a small
number of nucleotides. However, this is not true for
probes dual labelled at the 50- and 30-positions by a
D and an A interacting by FRET, in that the D-to-A dis-
tance cannot remarkably overcome the Fo¨rster radius.
We designed a probe of 22 nucleotides covering from
codon 51 up to the first base of codon 58 as we pre-
liminarily demonstrated that probe/target mis-
matches next to the probe ends, where D or A are
covalently bound, cause the greatest changes in the
FRET efficiency.11,12 In the present case, mismatches
at the polymorphic codon 57, which occur in the
cases of all variants except 0201 and 0302, are
expected to prevent pairing of the last three–four
bases on the side of the BHQ2. Such an ‘unzipping’
of the duplex structure should let A approach D and
cause a sizeable decrease in the donor-fluorescence
decay time (tD). It is worth noting that the eight
DQB1 alleles are all identical from codon 58 to
codon 60, thus further extending the probe would
prevent unzipping.
Figure 3. Fluorescence decay of the TAMRA donor of the probe
bound to the oligonucleotide mimicking the sequence of the
DQB1-0201 allele. Grey dots represent the experimental data
after subtraction of the slow decay of TAMRA molecules left
free in the solution and black line as a fitting curve with best-
fitting parameters tD ¼ 2722.61 ps and 652.3 counts as the
background. Open dots: residuals.
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As mentioned in Section 2.3.1 the decay patterns
recorded in the case of oligonucleotides exhibit fast
initial transients of negligible amplitudes, thus
showing that dual-labelled fluorescent probes left
free in solution are virtually absent in our oligonucleo-
tide samples and testifying that the affinity of our new
22-nucleotide probe for the DQB1 template is
notably enhanced with respect to that of the 18-nu-
cleotide probe, with which we detected sizeable
amounts of non-hybridized probe molecules.11 The
tD values that we determined for the DQB1-0201
probe binding to each of the eight synthetic oligonu-
cleotides are listed in column (a) of Table 1. For all
hybrids, except those that the probe forms with the
variant sequences 05031 and 0602, we find signifi-
cantly different tD values. Most importantly, the great-
est value corresponds to the perfect matching of the
probe with the complementary 0201 oligonucleo-
tide. The next highest tD value is exhibited by the
probe binding the 0302 sequence, which is the only
one displaying a base composition identical to that
of the 0201 allele at codon 57. The manner in
which the other values of tD scale agrees with what
we previously observed by using a probe containing
18 instead of 22 nucleotides.11 Moreover, the differ-
ences among the data in column (a) confirm that
the type of mismatch remarkably influences the
decay time. In fact, the 0501 and 0602 alleles,
having only one nucleotide variation in the same pos-
ition of codon 57 (CAA and CTA, respectively) display
significantly different tD values upon hybridization to
the 0201 probe.
3.2. HLA-II DQB1 typing of purified, non-amplified
genomic DNA
In order to validate our FRET-based HLA-II DQB1
typing approach set with synthetic oligonucleotides,
we tested the system with non-PCR-amplified
genomic DNAs extracted from five HLA-homozygous
lymphoblastoid cell lines with different DQB1 specifi-
cities.6 Upon the modifications of the setup as to the
excitation/collection optics described in Sub-section
2.3, the corresponding tD values were measured
(see data listed in column (b) of Table 1). These
values are surprisingly equal, within the experimental
errors, to those obtained with the oligonucleotides
corresponding to the same DQB1 alleles, which are
listed on the same lines in column (a), in spite of
the fact that these measurements were performed
on entire genomic DNA.
To assess the possibility of recognizing the presence
of the 0201 variant also in the case of a heterozygous
genomic DNA, we measured the fluorescence decays
for the two 50:50 mixtures of 0201 with 0302 and
Figure 4. (a) Raw experimental decay patterns of the samples
containing (black dots) the probe hybridized to genomic DNA
extracted from the PITOUT cell line, homozygous for the
DQB1-0201 allelic variant; (open dots) the dual-labelled
probe only. (b) Integral-normalized fluorescence decays F201
(black dots) and FPROBE (open dots) as obtained from the
decays in (a) upon subtraction of the slow decay component
of not-quenched TAMRA. Black line represents the fitting curve
YPROBE in Equation (1). (c) Decay D201 (grey dots) as obtained
by applying Equation (2) to the data in (b). Black line
represents the bi-exponential fit with best-fitting parameters
t’ ¼ 709.92 ps and tD ¼ 2724.43 ps. Open dots: residuals. The
arbitrary units in (b and c) are identical to allow the
comparison, in amplitude, of D201 to F201 (see Section 4).
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of 0302 with 0402. Such samples were chosen in that
the tD values obtained from the fittings of D201,EX and
D302,EX are the most similar (see column (b) in
Table 1). A predominant decay component with
time constant equal to the tD of D201,EX was found
in the fitting of curve D201-302,EX (former sample)
only. In the fitting of D302-402,EX the predominant
component had time constant equal to the tD of
D302,EX.
We conclude that the probe–template annealing is
correctly attained in both homozygous and heterozy-
gous situations.
3.3. Identification of DQB1-0201 allele in cell lysates
In order to verify whether our typing method is sen-
sitive enough to detect the DQB1-0201 allele directly
in cell lysates without prior DNA purification, we
performed measurements on both untreated and
RNAse-treated cell lysates obtained from PITOUT
(homozygous DQB1-0201) and RAJI (heterozygous
DQB1 0201-0501) cell lines. DQB1-0201 probe
was designed on the basis of the sequence of the
‘plus’ strand of DNA to avoid annealing with RNA.
However, to completely exclude any possible spurious
and non-specific annealing/interference derived from
RNA in a ‘dirty’ system such as that of the cell extracts,
we treated the cell lysates with RNAse. For both cell
lines, the fluorescence responses were not improved
in RNAse-treated as compared with untreated
lysates (data not shown), suggesting that RNAse treat-
ment is not a prerequisite step. Moreover, the fitting
of D201,LY returned a value tD ¼ 2724+4 ps, which
coincides with that returned by the fitting of D201,EX
in the first line of Table 1, column (b) within the ex-
perimental errors. We add that the tD component is
so much more relevant in D201,LY than in D201,EX as
to make the t0 component negligible in amplitude.
In the case of the RJ 2.2.5 lysate we also measured
the decay for its extracted DNA and obtained a D201-
501,EX curve in which the predominant component
had time constant equal to the tD of D201,EX. This
was also the major component in D201-501,LY.
4. Discussion
In this study we successfully developed a new
method to identify the DQB1-0201 variant, an
allele that is considered a genetic marker of suscepti-
bility to IDDM. Indeed, this allele is significantly over-
represented in patients with IDDM. The method is
based on the measurements of fluorescence decay
times performed with single photon sensitivity and
picosecond resolution. Non-amplified genomic
DNAs, purified from lymphoblastoid cell lines and
bearing different sequences in the polymorphic
region of the HLA-DQB1 gene, were hybridized with
a single DNA probe corresponding to the DQB1-
0201 allele. The same probe was also hybridized to
non-purified DNA contained in crude cell extracts.
The probe was dual-labelled with fluorescence
donor-and-acceptor chromophores at its opposite
ends. The chromophores undergo FRET, whose effi-
ciency is characterized by measuring the fluorescence
decay time tD of the donor. As the FRET efficiency, and
hence the tD value, is differently modified by the
number of probe-to-target mismatches and by their
positions, the hybrids formed by the probe with
each allelic variant are identified by distinct values
of tD. It is worth noting that the picosecond-laser ex-
citation wavelength we adopted, 532 nm, is very
close to the absorption peak of the TAMRA donor,
which falls at 556 nm, being not even absorbed by
the non-fluorescent BHQ2 acceptor.
We achieved our main goal by successive steps. We
first showed that the hybrids formed by allele-specific
HLA-II DQB1 oligonucleotides and the 0201 oligop-
robe can be identified through the different tD
values. Though in a previous work of ours we obtained
such a result by using an 18-nucleotides probe,11 re-
producing it with our 22-nucleotides probe, which we
deemed ideal for typing of genomic DNA templates,
was not obvious in that this probe covered codon
51, which is identical in all allelic variants (see
Figs 1 and 2). So much so that, as shown in Table 1,
for the mismatching oligonucleotides mimicking the
sequences of the DQB1 allelic variants other than
0201, we measure tD values that are both greater
than those for the 18-nucleotide probe (see, in par-
ticular, the cases of alleles 0501, 0502, 05031, and
0602, which produced very fast decays when hybri-
dized to the 18-nucleotide probe) and much more
similar to that measured for the perfectly matching
target oligonucleotide.11 For these target sequences
we had hypothesized an unzipping involving the first
five nucleotides, due to the double mismatch of the
second and fifth nucleotides. However, the addition
of the three nucleotides corresponding to codon 51
confers a greatly enhanced selectivity to the 22-
nucleotide probe, as reported in Section 3.1, and
does not prevent discrimination of the DQB1-0201
genotype. Beside the above considerations, the
scaling of the values in column (a) of Table 1 agrees
with the explanations that we presented in the
quoted work of the dependence of the tD changes
on both the number and the position of the base mis-
matches. Moreover, the 22-nucleotide probe pre-
serves the tD sensitivity to the variation of a single
nucleotide, as shown by the results reported in
Section 3.1 for the 0501 and 0602 alleles.
On the one hand, the tD measurements on entire
genomic DNA represent a very strong test of the
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probe selectivity. On the other hand, as they lead for
each allelic species to the same tD values that are
found for the corresponding oligonucleotide, these
tD measurements constitute the core result of our
work. The coincidence between the values in the
two columns in Table 1 and, in the case of DQB1-
0201, with the tD value obtained with cell lysate,
demonstrates that the conformation of the probe–
template duplex is identical in the three instances.
This is not surprising once the probe–template
annealing is correctly attained, which actually is the
main assumption underlying the rationale of the
method. In fact, on the local scale of 22 base pairs,
the tertiary structure of genomic DNA is not relevant,
as the persistence length of a DNA B-structured
double-helix is estimated to be 50 base pairs. In
our opinion the really astonishing feature is the
notable template specificity of the probe that leads
to the observation of a detectable tD component in
the decays obtained with genomic DNA (even when
non-purified), which prevails in all cases. We can
only attribute this result to the goodness of both the
design of the probe and the scaling of temperatures
during annealing. Moreover, designing the DQB1-
0201 probe on the basis of the sequence of the
‘plus’ strand of DNA prevents annealing with RNA,
thus making RNAse treatment of the cell extracts
not necessary.
We think that a very important role is played in this
work by the strategies we devised to determine the
values of tD. First they are suitable for taking into
account that not all the TAMRA molecules that con-
tribute to the detected fluorescence-decay patterns
decay with time-constant tD. There can be dual-
labelled fluorescent probes free in solution, thus
keeping their natural conformation as single-stranded
probe and contributing decay-components shorter
than tD. There might also be probes lacking the
BHQ2 acceptor as well as TAMRA molecules not
bound to the probe: both of them decay slower than
any TAMRA quenched via FRET by the presence of a
more-or-less distant BHQ2. Moreover, in the case of
lysates, flavine mononucleotide fluorescence adds to
the TAMRA decay. The overall effect is that the experi-
mental decay patterns deviate from single exponen-
tials. Finally, the binding of the probe to the specific
target sequences is contrasted by partial annealing
to other genomic DNA regions other than the
allelic-variant under examination. However, a neutral
application to all experimental decay patterns of the
strategy described in Section 2 and already used in a
previous work of ours,11 brought to decays (Dx) of re-
markable amplitudes that could be fitted by the sum
of two exponentials in the case of homozygous geno-
types. The faster one has a decay time t0 ¼ 709+
67 ps, which is attributable to the partially annealed
probes, while the slower one decays with the tD
values reported in Table 1. For heterozygous geno-
types, beside t0, we recognized the decay of the
allele best matching the probe as the predominant
one. The further decay component was too low in
amplitude to allow identification of the second
allele, which might be defined by using a second
allele-specific probe. Nonetheless, we attained our
primary goal, that is, the identification of the DQB1-
0201 allele in a heterozygous genotype even in the
presence of the allele with the most similar tD (i.e.
DQB1-0302). The result obtained for the allele
mixture of DQB1-0302 with DQB1-0402 showed
that the method is free from the risk of detecting
false positives (i.e. erroneously inferring the presence
of the 0201 allele) even when the 0302 allele is
present. Finally, it is worth noting that, when DQB1-
0201 was present, we could distinguish between
homozygous and heterozygous genotypes.
The fact that superimposable results were obtained
with crude cell extracts without the need of DNA puri-
fication, makes our HLA typing method greatly advan-
tageous with respect to other current techniques. As
to the performance in a clinical setting, we think it
is worth noting that, once the cell lysates are pre-
pared, our technique only requires common buffers
and negligible amounts of dual-labelled probes, with
no need of enzymatic reactions or temperature-
controlled incubation steps. Firstly, this makes the
analysis easier and reduces the risks of sample
contamination/degradation. Moreover, by virtue of
the reduced amount of consumables needed, our
method combines the timelines of the most state-
of-art genotyping techniques based on PCR amplifica-
tion with superior cost-effectiveness, which is a desir-
able feature in view of an application to population
screening. Finally, the HLA typing method reported
here is relatively simple; the instrumentation that is
needed is not particularly expensive and is prone to
be adapted for routine use in a diagnostic laboratory.
The single-photon sensitivity, which is intrinsic to all
TCSPC techniques, also deserves some comment, in
that it can bring the low detection limit of genomic
DNA down to unprecedented values. In fact, as speci-
fied in Section 2.2, to keep the detected-photon rate
within the single-photon regime, we attenuated the
excitation laser by a factor of .103 and obtained
good fluorescence decay patterns from DNA samples
of few hundredths picomolar concentration. However,
there is no reason why, by using the full power of the
laser, we could not lower the DNA concentrations by
a factor of one thousand and obtain the same results
without increasing the data-acquisition times. We
think that, such a performance would be extremely de-
sirable in a clinical setting for applications in which the
sensitivity issue is definitely a matter of concern.
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Discriminating among the different alleles by the tD
values, as shown in this paper in the case of a highly
polymorphic gene, may allow the use of this method
not only for routine typing of HLA, but also for the
identification of specific ‘pathologic’ sequences, for
example mutations of genes causing inherited genetic
diseases or mutated oncogenes, in order to identify
the specific mutation in tumour tissues and, most im-
portantly, the extent of mutated genes in pre-neoplas-
tic lesions.
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